BR112013032017A2 - combinações terapêuticas para tratar malignidades hematológicas usando inibidores de piridopirimidinona de p13/mtor com bendamustina e/ou rituximab
- Google Patents
combinações terapêuticas para tratar malignidades hematológicas usando inibidores de piridopirimidinona de p13/mtor com bendamustina e/ou rituximab
Info
Publication number
BR112013032017A2
BR112013032017A2BR112013032017ABR112013032017ABR112013032017A2BR 112013032017 A2BR112013032017 A2BR 112013032017A2BR 112013032017 ABR112013032017 ABR 112013032017ABR 112013032017 ABR112013032017 ABR 112013032017ABR 112013032017 A2BR112013032017 A2BR 112013032017A2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc, Sanofi SafiledCriticalExelixis Inc
Priority claimed from PCT/US2012/042582external-prioritypatent/WO2012174327A1/en
Publication of BR112013032017A2publicationCriticalpatent/BR112013032017A2/pt
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
abstract not avaible
BR112013032017A2011-06-152012-06-15combinações terapêuticas para tratar malignidades hematológicas usando inibidores de piridopirimidinona de p13/mtor com bendamustina e/ou rituximab
BR112013032017A2
(pt)
Terapias combinadas para el tratamiento de neoplasias malignas hematológicas utilizando inhibidores de piridopirimidinona de pi3k/mtor con bendamustina y/o rituximab.